An Improved and Scalable Process for Celecoxib: A Selective Cyclooxygenase-2 Inhibitor

被引:24
作者
Reddy, Anumula Raghupathi [2 ]
Sampath, Alla [2 ]
Goverdhan, Gilla [2 ]
Yakambaram, Boja [2 ]
Mukkanti, Kagga [1 ,2 ]
Reddy, Padi Pratap [2 ]
机构
[1] JNT Univ, Inst Sci & Technol, Ctr Environm Sci, Hyderabad 500072, Andhra Pradesh, India
[2] Dr Reddys Labs Ltd, Dept Res & Dev, Integrated Prod Dev, R R Dist 500072, AP, India
关键词
COX-2; INHIBITORS; DERIVATIVES; PYRAZOLES; SC-58635;
D O I
10.1021/op800158w
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
An improved, scalable and commercially viable process is developed for an active pharmaceutical ingredient, celecoxib.
引用
收藏
页码:98 / 101
页数:4
相关论文
共 24 条
[1]   CYP2C9 structure-metabolism relationships:: Optimizing the metabolic stability of COX-2 inhibitors [J].
Ahlstroem, Marie M. ;
Ridderstroem, Marianne ;
Zamora, Ismael ;
Luthman, Kristina .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) :4444-4452
[2]  
Goldstein JL, 2000, AM J GASTROENTEROL, V95, P1681
[3]   Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: Replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere [J].
Habeeb, AG ;
Rao, PNP ;
Knaus, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (18) :3039-3042
[4]  
Letendre L. J., 2006, US Pat. , Patent, Patent No. [7141678B2, 7141678]
[5]  
MATSUO M, 1990, Patent No. 0418845
[6]  
Matsuo M., 1993, Eur. Pat. Appl, Patent No. 554829
[8]  
O Shea P, 2000, Patent No. [US6150534, 6150534]
[9]  
O'Shea P., 2001, US Patent, Patent No. [6,232,472, 6232472]
[10]   Synthesis of celecoxib via 1,3-dipolar cycloaddition [J].
Oh, Lynette M. .
TETRAHEDRON LETTERS, 2006, 47 (45) :7943-7946